Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U6 small nuclear 440, pseudogene (RNU6-440P)** is a non-coding RNA pseudogene that is related to the functional U6 small nuclear RNA (U6 snRNA)[7]. U6 snRNA is a key component of the spliceosome, the molecular machine responsible for removing introns from nuclear pre-mRNA during splicing[3][1]. However, as a pseudogene, RNU6-440P represents a genomic sequence similar to U6 snRNA but is typically not transcribed into a functional product and does not contribute to spliceosomal activity. Pseudogenes like RNU6-440P may arise from duplication or retrotransposition of functional genes and generally lack coding potential due to disruptive mutations or lack of necessary regulatory elements[2][5]. While some pseudogenes have been shown to gain regulatory roles (such as producing non-coding RNAs involved in gene expression regulation or acting as molecular decoys), no specific function or clinical significance has been described for RNU6-440P[2][7]. This gene has no known implications as a therapeutic target, no reported drug interactions, no established biomarker use, and no known safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 440, pseudogene (RNU6-440P).